Dave Nellesen

Dave Nellesen is a seasoned professional with extensive experience in the biopharmaceutical and biotechnology sectors. As a Principal at Analysis Group since April 2008, Dave leads projects focused on market access and reimbursement for novel therapeutics. Prior to this role, Dave served as a Consultant at Pittiglio Rabin Todd & McGrath, managing product development and operational strategies. Commencing as a co-founder of Nanosense, a startup specializing in nanowire biosensor technology, Dave also contributed to business development at Palo Alto Research Center. Earlier experience includes a significant tenure at Incyte, where Dave managed intellectual property and worked on genomic products. Academic credentials include an MBA from the University of California, Berkeley, a Ph.D. in Molecular Biology from UC San Diego, and a BS in Biochemistry from UCLA.